Soft capsule formulation containing nintedanib ethane sulfonate

TW202635306APending Publication Date: 2026-09-01FUJI CAPSULE
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114150693
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-01-08
Filing Date
2025-12-23
Publication Date
2026-09-01

Smart Images

  • Figure TWG2TA001074990_001
    Figure TWG2TA001074990_001
  • Figure TWG2TA001074990_002
    Figure TWG2TA001074990_002
  • Figure TWG2TA001074990_003
    Figure TWG2TA001074990_003
Patent Text Reader

Abstract

The objective of this invention is to provide a soft capsule formulation of nintedanib ethanesulfonate with excellent solubility, and a method for manufacturing the soft capsule formulation. This invention relates to a soft capsule formulation in which the capsule contents, comprising nintedanib ethanesulfonate, medium- and long-chain triglycerides, hard fat, and a specific surfactant, are coated by a capsule membrane.
Need to check novelty before this filing date? Find Prior Art